Galmed Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Year End 2020 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. ABBV
3. MU
4. IBM
5. SPY
6. ACN
7. NVDA
8. PRIM
9. META
10. PFE

Go back to Galmed Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Year End 2020 Financial Results

Galmed Pharma (GLMD) Misses Q4 EPS by 12c

March 18, 2021 7:07 AM EDT

Galmed Pharma (NASDAQ: GLMD) reported Q4 EPS of ($0.48), $0.12 worse than the analyst estimate of ($0.36).

For the three and twelve months ended December 31, 2020, the Company recorded a net loss of $10.3 million and $28.8 million or $0.48 and $1.35 per share, respectively, compared with a net loss of $8.3... More